An Unexpected Complete Remission of Advanced Intestinal-Type Vulvar Adenocarcinoma after Neoadjuvant Chemotherapy: A Case Report and a Literature Review
Vulvar cancer represents approximately 3%-5% of all gynecological malignancies. Squamous cell carcinoma is the most frequent histotype, whereas melanomas, adenocarcinomas, basal cell carcinomas, and sarcomas are much less common. Intestinal-type adenocarcinoma is a rare variant of vulvar carcinoma w...
Saved in:
Main Authors: | Angela Musella (Author), Claudia Marchetti (Author), Laura Salerno (Author), Laura Vertechy (Author), Roberta Iadarola (Author), Irene Pecorella (Author), Pierluigi Benedetti Panici (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vulvar Malignancy in Neurofibromatosis Syndrome
by: Angela Musella, et al.
Published: (2013) -
Neoadjuvant chemotherapy with paclitaxel/carboplatin/bevacizumab in advanced vulvar cancer: Time to rethink standard of care?
by: Madison R. Klavans, et al.
Published: (2020) -
SMAD4 loss is associated with response to neoadjuvant chemotherapy plus hydroxychloroquine in patients with pancreatic adenocarcinoma
by: Naomi Fei, et al.
Published: (2021) -
Disease-free remission of metastatic adrenocortical carcinoma following en bloc tumor resection and neoadjuvant chemotherapy for suspected adrenohepatic infiltration
by: Daniel Pasquale Cinelli, et al.
Published: (2021) -
Neoadjuvant Chemotherapy Current Applications in Clinical Practice
Published: (2012)